Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. A, MM.1S.

Slides:

Advertisements

Similar presentations

Volume 68, Issue 4, Pages (October 2005)

Advertisements

Selinexor combines with immune checkpoint blockade to slow B16F10 melanoma tumor growth. Selinexor combines with immune checkpoint blockade to slow B16F10.

TRAIL-induced apoptosis of authentic myeloma cells does not correlate with the procaspase-8/cFLIP ratio by Andrew Spencer, Sung-Lin Yeh, Karly Koutrevelis,

PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells Jian Yao, Tetsuo Morioka, Takashi Oite Kidney.

Volume 128, Issue 4, Pages (April 2005)

Figure 4 Glatiramer acetate treatment negatively regulates IFN-β production by targeting components of the IFN-β enhanceosome (A) Wild-type (WT) monocytes.

A, Western blot analysis of fetuin-A in AGA (lanes 1–5 and 10–13) and IUGR (lanes 6–9, 14, and 15) UC plasma samples. A, Western blot analysis of fetuin-A.

Western blot analysis of fetuin-A in AGA and IUGR UC plasma after digestion with glycosidases showing the elimination of the IUGR-related isoforms following.

Human Keratinocytes Respond to Osmotic Stress by p38 Map Kinase Regulated Induction of HSP70 and HSP27 M. Garmyn, A. Pupe Journal of Investigative Dermatology

p38 MAPK activation is required for phosphorylation of Akt at Ser473.

AMPK induces VEGF-A production by upregulating ERK signaling.

Silva H Hanissian, Raif S Geha Immunity

Overexpression of BTAK/Aurora-A in ovarian carcinoma.

Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.

The effects of laminarin, PMA and zymosan on PKC phosphorylation.

Elevated pAkt level in ptena−/−ptenb−/− mutants is suppressed by LY and to a lesser extent by sunitinib. Elevated pAkt level in ptena−/−ptenb−/−

Time-dependent phosphorylation profile of p38-MAPK and JNKs in samples from gills of Mytilus galloprovincialis specimens subjected to hyperthermia (30°C).

Phosphorylation of AMPK-Thr172 before and after metformin treatment in muscle from subjects with type 2 diabetes. Phosphorylation of AMPK-Thr172 before.

CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.

Effect of the selective pharmacological inhibitors used.

BEZ235 induces MAPK signaling in a FOXO3A-dependent manner.

Curcumin-generated ROS activates Chk1 and Chk2 kinases.

The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.

Quantification of NMT knockdown.

Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)

Gramicidin A (GA) decreases HIF protein expression in RCC cells.

FOXO3a phosphorylation and expression.

Synergistic effect of CNP and doxorubicin (DOX) on thiol oxidation.

A, ATP production by PC3 prostate cancer cells after treatment with oligonucleotide/Lipofectin complexes. a, ATP production by PC3 prostate cancer cells.

Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.

Identification of NSC as a FADD-kinase inhibitor.

FMRP S499 is phosphorylated by multiple kinases in vitro.

Effect of LY on phosphorylation of various MAP kinase substrates in HeLa cells in vitro. Effect of LY on phosphorylation of various MAP kinase.

Activation of CHOP and DR5 by DIM-C-pPhtBu.

BME treatment increases granzyme B expression in NK 3.3 cells.

DNA damage signaling regulates mutant p53 ubiquitination.

Geldanamycin-induced endocytosis and down-regulation of ErbB2 in cells expressing ErbB2 only. Geldanamycin-induced endocytosis and down-regulation of ErbB2.

Inhibition of stress-associated MAPK signaling attenuates SASP expression in CAFs. A, N-CAFs were treated with 100 nmol/L GEM plus DMSO or the above-listed.

Lamellarin D induces cell death through a Fas-independent pathway.

Down-regulation of the erbB-2 receptor by trastuzumab decreases Akt kinase activation but not MAPK activation. Down-regulation of the erbB-2 receptor by.

Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.

ONC201 activates an ISR, decreases cyclin D1 expression, and causes an accumulation of cells in G1 in TNBC cells sensitive to the compounds' antiproliferative.

Effect of UV irradiation on PTHRP gene expression.

sir2α null cells differentiate in vitro.

Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.

A. A. Honokiol inhibits TNF-induced NF-κB activation, IκBα phosphorylation, and IκBα degradation. Honokiol inhibits TNF-induced activation of NF-κB. H1299.

Angiogenesis in tumors formed by cells varying in the expression of CXCR2. Angiogenesis in tumors formed by cells varying in the expression of CXCR2. A,

Characterization of the complex formed at the Fra-1 RCE1.

A, P causes G2-M arrest with apoptosis in asynchronous population of PC-3 when exposed to 1.5 and 5 μmol/L P for various time points. A, P

Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.

PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.

Expression of dominant-negative RasN17 completely suppresses Ras activation in Rh1 cells. Expression of dominant-negative RasN17 completely suppresses.

Effects of EGCG on the anchorage-independent growth of EFT cells.

IGF-II antibodies inhibited IGF-II-induced phosphorylation of IGF-IR and insulin receptor (IR) in the breast cancer MCF-7 cells. IGF-II antibodies inhibited.

Changes in signal transduction pathway induced by gefitinib.

ODC protein expression in paired benign and cancer tissue obtained from patients with PCA. The protein expression was measured by immunoblot analysis in.

A, effect of Z-VAD treatment on synchronized HeLa MR cells.

SAHA blocks IR-induced increase of RAD51 protein in MM cells.

Induction of PARP cleavage (A) and activation of caspases (B) after treatment with a combination of TRAIL and cisplatin. Induction of PARP cleavage (A)

Expression and induction of HER2 and HPSE in 231BMBC cells.

Posttranslational phosphorylation of p53 by platinum drugs in ovarian tumor cells. Posttranslational phosphorylation of p53 by platinum drugs in ovarian.

RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.

Epstein–Barr Virus Coopts Lipid Rafts to Block the Signaling and Antigen Transport Functions of the BCR Michelle L Dykstra, Richard Longnecker, Susan.

Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.

Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.

T3 or T4 induces MAPK activation in myeloma cells.

Effects of NMT siRNAs on MARCKS and c-Src.

I3C reduces the level of Cdc25A protein in breast cancer cells.

D-GM3 promotes uPAR clustering on the cell surface and activates p38 MAPK. A, uPAR expression in cells was either knocked down by treatment with 4 independent.

Time course of NMT knockdown.

Presentation transcript:

Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. A, MM.1S cells were treated with 10 μmol/L 8-Cl-Ado for the indicated times. B, MM.1S cells were exposed to 10 μmol/L of the drug indicated for 4 h. Cells were lysed as described in Materials and Methods. Protein (30 μg) was separated by gel electrophoresis, transferred to PVDF membrane, and probed with phospho-p38 MAPK (Thr180/Tyr182) antibody. Blots were stripped and reprobed with total p38 MAPK antibody to ensure that drug treatment does not affect total protein levels and to ensure equal loading and transfer. Representative experiments; two additional studies yielded equivalent results. Kulsoom Ghias et al. Mol Cancer Ther 2005;4:569-577 ©2005 by American Association for Cancer Research